IGF2 interacts with the imprinted gene Cdkn1c to promote terminal differentiation of neural stem cells

Development. 2023 Jan 1;150(1):dev200563. doi: 10.1242/dev.200563. Epub 2023 Jan 12.

Abstract

Adult neurogenesis is supported by multipotent neural stem cells (NSCs) with unique properties and growth requirements. Adult NSCs constitute a reversibly quiescent cell population that can be activated by extracellular signals from the microenvironment in which they reside in vivo. Although genomic imprinting plays a role in adult neurogenesis through dose regulation of some relevant signals, the roles of many imprinted genes in the process remain elusive. Insulin-like growth factor 2 (IGF2) is encoded by an imprinted gene that contributes to NSC maintenance in the adult subventricular zone through a biallelic expression in only the vascular compartment. We show here that IGF2 additionally promotes terminal differentiation of NSCs into astrocytes, neurons and oligodendrocytes by inducing the expression of the maternally expressed gene cyclin-dependent kinase inhibitor 1c (Cdkn1c), encoding the cell cycle inhibitor p57. Using intraventricular infusion of recombinant IGF2 in a conditional mutant strain with Cdkn1c-deficient NSCs, we confirm that p57 partially mediates the differentiation effects of IGF2 in NSCs and that this occurs independently of its role in cell-cycle progression, balancing the relationship between astrogliogenesis, neurogenesis and oligodendrogenesis.

Keywords: Genomic Imprinting; Insulin-like growth factor 2; Neural Stem Cells; Neurosphere cultures; p57.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cyclin-Dependent Kinase Inhibitor p57* / genetics
  • Genomic Imprinting*
  • Insulin-Like Growth Factor II* / genetics
  • Mice
  • Mice, Inbred C57BL
  • Neural Stem Cells* / cytology
  • Neurogenesis* / genetics
  • Neurons* / cytology

Substances

  • Cyclin-Dependent Kinase Inhibitor p57
  • IGF2 protein, mouse
  • Cdkn1c protein, mouse
  • Insulin-Like Growth Factor II